FDA vaccine committee votes to endorse J&J COVID-19 vaccineCOVID-19 vaccine
26 Feb 2021
VaccineEmergency Use Authorization
The FDA's vaccine advisory committee voted Feb. 26 to unanimously recommend the agency grant emergency use authorization to Johnson & Johnson's COVID-19 vaccineCOVID-19 vaccine candidate.
The panel voted on just one question: Based on the totality of scientific evidence available, do the benefits of the Johnson & Johnson COVID-19 vaccineCOVID-19 vaccine outweigh its risks for use in individuals 18 years of age and older?
All members of the committee voted "yes" to recommend the FDA grant emergency use authorization for the vaccine.
The FDA is expected to follow the committee's recommendation and issue an emergency use authorization for the vaccine as soon as Feb. 27, according to The New York Times.
The vaccine committee, called the Vaccines and Related Biological Products Advisory Committee, is made up of outside experts, including physicians, academics, disease experts and biostatisticians. They have all been vetted for conflicts of interest before becoming members of the committee.
Organizations
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.